We provide evidence that, rather than being a passenger alteration derived from the increased genomic instability shown by basal-like and BRCA1 primary breast tumors [14, 25], CUL4A overexpression would confer selective advantage to tumor cells. The gene discussed is BRCA1; the disease is neoplasm.